1. Use of rapid cardiac magnetic resonance imaging to guide chelation therapy in patients with transfusion-dependent thalassaemia in India: UMIMI study
- Author
-
Redha Boubertakh, Vidhur Mahajan, Alexander Rikowski, Judith Walker, Prabhar Srivastava, Louise McGrath, Emmanuel Ako, Tenzin Seldon, Katia D. Menacho Medina, Amita Mahajan, Vineeta Ojha, Sanjiv Sharma, Harsh Mahajan, Rajiv Kumar Bansal, J Malcolm Walker, Tulika Seth, Kartik P. Ganga, Nabila Mughal, Amna Abdel-Gadir, James C. Moon, Veena Khanna, Surya Pratap, and João B Augusto
- Subjects
Adult ,medicine.medical_specialty ,Thalassemia ,Iron ,Ventricular Function, Left ,Cohort Studies ,Cardiac magnetic resonance imaging ,Internal medicine ,Medicine ,Transfusion dependent thalassemia ,Humans ,In patient ,Chelation therapy ,Prospective Studies ,medicine.diagnostic_test ,business.industry ,Health Policy ,beta-Thalassemia ,Stroke Volume ,medicine.disease ,Magnetic Resonance Imaging ,Chelation Therapy ,Cardiology ,Cardiology and Cardiovascular Medicine ,business ,Cardiac magnetic resonance - Abstract
Aims To explore the impact of incorporating a faster cardiac magnetic resonance (CMR) imaging protocol in a low–middle-income country (LMIC) and using the result to guide chelation in transfusion-dependent patients. Methods and results A prospective UK–India collaborative cohort study was conducted in two cities in India. Two visits 13 months apart included clinical assessment and chelation therapy recommendations based on rapid CMR results. Participants were recruited by the local patient advocate charity, who organized the patient medical camps. The average scanning time was 11.3 ± 2.5 min at the baseline and 9.8 ± 2.4 min (P Conclusion For thalassaemia patients in an LMIC, a simplified CMR protocol linked to therapeutic recommendation via the patient camp model led to enhanced chelation therapy and a reduction in cardiac iron in 1 year.
- Published
- 2021